Abstract:
Anadis Ltd and Starpharma Holdings Limited announced today that they have established a
partnership to investigate applications of their combined technologies to respiratory protection
and biodefense.
This research involves the use of polyclonal antibodies, harvested from bovine colostrum and
combined with Starpharma’s nano-scale dendrimer molecules to provide immediate short term
respiratory protection from airborne biological agents such as Anthrax and Plague.